With the potential to raise as much as $1.15 billion, SailPoint’s IPO is attracting significant interest from major institutional investors, including affiliates of AllianceBernstein (AB ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Crunchbase is the leading platform for professionals to ...
Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...
Investors in defense stocks seem a bit nervous at the prospect ... Well, simply put, because Anduril might IPO soon. Since its establishment in 2017 (by, among others, Oculus founder Palmer ...
Apple (NASDAQ: AAPL) has been a public company for ... declared five stock splits since its 1980 initial public offering (IPO). The stock had several 2-for-1 splits between 1987 and 2005 (June ...
For over 50 years, Nasdaq has been a leader in the exchange space through our technology innovations. We built our IPO process in partnership with the investment banking community, ensuring that ...
Also, find out which stocks you should invest in with your tax ... However, due to stock splits over the years, the true, adjusted IPO price as of 2025 is just $2.13 per share.
The units are listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “KFIIU” as of February 5, 2025. After the securities comprising the units begin separate ...
has priced its initial public offering or IPO of 8.8 million shares of common stock at $16.00 each, raising gross proceeds of $140 million. The shares would debut on the Nasdaq Global Market on ...
Berkshire doesn't disclose which trades are made by which person, but Buffett almost certainly manages the largest positions like Apple (NASDAQ: AAPL). Berkshire had 50% of its 41-stock portfolio ...
Anbio Biotechnology NNNN IPO will take place February, 19 on the NASDAQ exchange under the ticker NNNN. The company is offering shares at an expected price between $5.00 and $6.00 per share with an ...
Quantum BioPharma retains 25.71% ownership in Celly Nutrition, positioning itself strategically to benefit from the upcoming capital raise and IPO. The royalty agreement with Celly Nutrition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results